Synopsis
Synopsis
0
JDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Acamprosate
2. Acamprostate
3. Acetyl Homotaurinate, Calcium
4. Acetylhomotaurinate, Calcium
5. Acetylhomotaurine, Calcium
6. Acetylhomotaurine, Sodium
7. Aotal
8. Calcium Acetyl Homotaurinate
9. Calcium Acetylhomotaurinate
10. Calcium Acetylhomotaurine
11. Campral
12. Campral Ec
13. N Acetylhomotaurine
14. N Acetylhomotaurine, Monolithium Salt
15. N Acetylhomotaurine, Monopotassium Salt
16. N Acetylhomotaurine, Monosodium Salt
17. N-acetylhomotaurine
18. N-acetylhomotaurine, Calcium (2:1) Salt
19. N-acetylhomotaurine, Magnesium (2:1) Salt
20. N-acetylhomotaurine, Monolithium Salt
21. N-acetylhomotaurine, Monopotassium Salt
22. N-acetylhomotaurine, Monosodium Salt
23. N-acetylhomotaurine, Zinc (2:1) Salt
24. Regtect
25. Sodium Acetylhomotaurine
26. Zulex
1. 77337-73-6
2. Campral
3. Campral Ec
4. Alcomed
5. Sobriol
6. Aotal
7. Calcium 3-acetamidopropane-1-sulfonate
8. Calcium Acetylhomotaurinate
9. Acamprosate Calcium [usan]
10. Calcium N-acetylhomotaurinate
11. Calcium 3-(acetylamino)propane-1-sulfonate
12. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
13. Acamprosate (calcium)
14. Nsc-759186
15. Chebi:51042
16. Sn-102
17. 59375n1d0u
18. Calcium Bis(3-acetamidopropane-1-sulfonate)
19. Dsstox_cid_27529
20. Dsstox_rid_82399
21. Dsstox_gsid_47529
22. 77337-73-6 (calcium Salt); 77337-76-9 (free Acid).
23. Calcium Acamprosate
24. Cas-77337-73-6
25. Calcium(2+) 3-(acetylamino)propanesulphonate
26. Ncgc00167462-01
27. Einecs 278-665-3
28. N-acetylhomotaurine Calcium
29. Unii-59375n1d0u
30. Campral (tn)
31. Regtect (tn)
32. Calcium;3-acetamidopropane-1-sulfonate
33. Calcium 3-(acetylamino)propanesulphonate
34. Acamprosate Calcium- Bio-x
35. Schembl137771
36. 3-(acetylamino)-1-propanesulfonic Acid Calcium Salt
37. Acamprosate Calcium [mi]
38. Chembl2068724
39. Dtxsid6047529
40. Acamprosate Calcium (jan/usan)
41. Acamprosate Calcium [jan]
42. Hms3264j11
43. Hms3713l22
44. Pharmakon1600-01505711
45. Acamprosate Calcium [mart.]
46. Tox21_112466
47. Tox21_302606
48. Acamprosate Calcium [usp-rs]
49. Acamprosate Calcium [who-dd]
50. Mfcd00886588
51. Nsc759186
52. Akos015895192
53. Ab07649
54. Ac-5599
55. Calcium 3-acetamido-1-propanesulfonate
56. Ccg-213526
57. Ks-5292
58. Nsc 759186
59. Acamprosate Calcium [orange Book]
60. Ncgc00256899-01
61. Acamprosate Calcium [ep Monograph]
62. Ba164134
63. Acamprosate Calcium [usp Monograph]
64. Db-056209
65. Ft-0621712
66. 3-acetamido-1-propanesulfonate Calcium
67. 3-acetamido-1-propanesulphonate Calcium
68. D02780
69. T71327
70. 3-acetamido-1-propanesulfonic Acid Calcium Salt
71. A839056
72. Calcium 3-(acetylamino)propane-1-sulphonate
73. Q27122289
74. 3-(acetylamino)-1-propanesulfonic Acid Hemicalcium Salt
75. Z1696861853
76. 5-methoxy-2-methyl-1-propyl-1h-indole-3-carboxylicacid
77. 1-propanesulfonic Acid, 3-(acetylamino)-, Calcium Salt (2:1)
| Molecular Weight | 400.5 g/mol |
|---|---|
| Molecular Formula | C10H20CaN2O8S2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 400.0286988 g/mol |
| Monoisotopic Mass | 400.0286988 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 202 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 2 | |
|---|---|
| Drug Name | Acamprosate calcium |
| Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
| Active Ingredient | Acamprosate calcium |
| Dosage Form | Tablet, delayed release |
| Route | Oral |
| Strength | 333mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
| 2 of 2 | |
|---|---|
| Drug Name | Acamprosate calcium |
| Drug Label | Campral (acamprosate calcium) is supplied in an enteric-coated tablet for oral administration. Acamprosate calcium is a synthetic compound with a chemical structure similar to that of the endogenous amino acid homotaurine, which is a structural analo... |
| Active Ingredient | Acamprosate calcium |
| Dosage Form | Tablet, delayed release |
| Route | Oral |
| Strength | 333mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Glenmark Generics; Barr Labs Div Teva |
Alcohol Deterrents
Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Category : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K30 is used as a binder for tablets and capsules.
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : ProBlend (SMCC) is a co-processed excipient consists of microcrystalline cellulose & colloidal silicon dioxide, used as a diluent & binder in OSDs.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Capsule, Suspension, Tablet
Grade : Oral (Pharma Grade)
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Co-Processed Excipients, Fillers, Diluents & Binders
Excipient Details : Microlose (Lactose Monohydrate & Microcrystalline Cellulose) is used as a diluent in oral dosage forms such as tablets.
Pharmacopoeia Ref : USP-NF,BP,EP,IP
Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Brand Name : Microcrystalline Cellulose
Application : Fillers, Diluents & Binders
Excipient Details : Microcrystalline Cellulose is most commonly used filler and binder in drug formulations, together with Lactose.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Fillers, Diluents & Binders
Excipient Details : TABCELL serves as an excellent excipient for solid dosage forms, providing numerous advantages for tablet formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
Dosage Form : Tablet
Grade : Oral
Category : Granulation, Lubricants & Glidants, Surfactant & Foaming Agents
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm
Ingredient(s) : Magnesium Stearate
Dosage Form : Granule / Pellet, Tablet
Grade : Oral & Topical
Category : Controlled & Modified Release, Lubricants & Glidants
Application : Controlled & Modified Release, Lubricants & Glidants
Excipient Details : Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.
Excipients Web Link
Application : Fillers, Diluents & Binders
Excipient Details : It is used as an adhesive agent.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as K17, K25, K90 and VA-64
Ingredient(s) : Povidone K30
Application : Lubricants & Glidants
Excipient Details : TABLUBE is one of the oldest and most widely used lubricants for tablet, capsules and other solid dosage forms.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Brand Name : Magnesium Stearate
Application : Lubricants & Glidants
Excipient Details : Magnesium stearate is the magnesium salt of stearic acid. It acts as a lubricating agent in tablet manufacturing.
Pharmacopoeia Ref : USP/BP/EP/PH.EUR
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Dosage Form : Tablet, Capsule, Granule / Pellet, Injectable / Parenteral
Grade : Oral, Topical
Category : API Stability Enhancers, Fillers, Diluents & Binders, Lubricants & Glidants, Solubilizers
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral & Topical
Category : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Brand Name : Magnesium Stearate
Application : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Excipient Details : Magnesium Stearate is used in pharmaceuticals as lubricant and in cosmetics as a thickening agent and emulsifier.
Pharmacopoeia Ref : I.P./B.P./N.F./E.P
Technical Specs : Not Available
Ingredient(s) : Magnesium Stearate
Grade : Oral
Category : Fillers, Diluents & Binders, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Lubricants & Glidants
Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm
Ingredient(s) : Magnesium Stearate
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
16
PharmaCompass offers a list of Acamprosate Calcium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acamprosate Calcium manufacturer or Acamprosate Calcium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acamprosate Calcium manufacturer or Acamprosate Calcium supplier.
PharmaCompass also assists you with knowing the Acamprosate Calcium API Price utilized in the formulation of products. Acamprosate Calcium API Price is not always fixed or binding as the Acamprosate Calcium Price is obtained through a variety of data sources. The Acamprosate Calcium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zulex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zulex, including repackagers and relabelers. The FDA regulates Zulex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zulex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zulex manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zulex supplier is an individual or a company that provides Zulex active pharmaceutical ingredient (API) or Zulex finished formulations upon request. The Zulex suppliers may include Zulex API manufacturers, exporters, distributors and traders.
click here to find a list of Zulex suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zulex DMF (Drug Master File) is a document detailing the whole manufacturing process of Zulex active pharmaceutical ingredient (API) in detail. Different forms of Zulex DMFs exist exist since differing nations have different regulations, such as Zulex USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zulex DMF submitted to regulatory agencies in the US is known as a USDMF. Zulex USDMF includes data on Zulex's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zulex USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zulex suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zulex Drug Master File in Korea (Zulex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zulex. The MFDS reviews the Zulex KDMF as part of the drug registration process and uses the information provided in the Zulex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zulex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zulex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zulex suppliers with KDMF on PharmaCompass.
A Zulex CEP of the European Pharmacopoeia monograph is often referred to as a Zulex Certificate of Suitability (COS). The purpose of a Zulex CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zulex EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zulex to their clients by showing that a Zulex CEP has been issued for it. The manufacturer submits a Zulex CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zulex CEP holder for the record. Additionally, the data presented in the Zulex CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zulex DMF.
A Zulex CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zulex CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zulex suppliers with CEP (COS) on PharmaCompass.
A Zulex written confirmation (Zulex WC) is an official document issued by a regulatory agency to a Zulex manufacturer, verifying that the manufacturing facility of a Zulex active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zulex APIs or Zulex finished pharmaceutical products to another nation, regulatory agencies frequently require a Zulex WC (written confirmation) as part of the regulatory process.
click here to find a list of Zulex suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zulex as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zulex API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zulex as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zulex and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zulex NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zulex suppliers with NDC on PharmaCompass.
Zulex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zulex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zulex GMP manufacturer or Zulex GMP API supplier for your needs.
A Zulex CoA (Certificate of Analysis) is a formal document that attests to Zulex's compliance with Zulex specifications and serves as a tool for batch-level quality control.
Zulex CoA mostly includes findings from lab analyses of a specific batch. For each Zulex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zulex may be tested according to a variety of international standards, such as European Pharmacopoeia (Zulex EP), Zulex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zulex USP).